Steven J Gomo

Director Steven J Gomo sells 2,000 MU shares for $1.57M; third open-market sale at stock near 52-week highs.

Director Steven J Gomo sold 2,000 shares of Micron for roughly $1.57M, reducing his direct stake from just over 19,000 shares to approximately 17,000 shares. The sales occurred while the stock trades near its 52-week high, a departure from his prior selling history at this company—his most recent prior sale in December was followed by the stock climbing significantly over subsequent months, indicating poor timing on that exit. Gomo's track record across all holdings is consistently one-directional: all of his open-market activity in the prior three years has been sales, with ten prior dispositions across all his holdings and not a single open-market purchase, yet his timing on prior sells has been uniformly poor as the stock has risen after each exit. Micron itself presents a profitable enterprise with strong recent revenue growth and a sizable market value, trading at a relatively elevated multiple. The director's continued selling despite repeated poor timing outcomes on prior exits, combined with the stock's proximity to its 52-week high, suggests neither urgent liquidity pressure nor conviction-driven capital redeployment—this appears to be a routine trimming of a legacy position that has appreciated substantially.

Director GOMO STEVEN J sold 5,000 shares of MU at $263.63 for $1,318,150.00; stock now at $276.27, up 33.2% in 30 days.

GOMO STEVEN J sold 5,000 shares (20.7% of his pre-transaction holdings) on 2025-12-19 at $263.63 per share, bringing holdings to 19,139 shares from 24,139. The sale occurred near the 52-week high ($276.59), with the stock trading at $276.27 today—only 0.1% below its 52-week peak. In the 30 and 90 days following the transaction, MU has appreciated 33.2% and 70.8%, respectively, indicating the sale was not well-timed relative to subsequent price action. Across his cross-ticker track record, the insider's prior 9 open-market sells averaged a 90-day well-timed rate of 22.22%, and his average 90-day return after those sales was 4.5%—a positive figure indicating his sells have historically been poorly timed. The company exhibits strong fundamentals: $13.6B in latest-quarter revenue with 48.8% annual growth, $5.2B net income, a 26.11 P/E, and $310.9B market cap. The director's reduction in stake following substantial stock price appreciation warrants monitoring of future transactions.

Director GOMO sold 15,000 NTNX shares at $75.10; holdings decline 22.7% to 51.2K shares.

Director Steven J. Gomo sold 15,000 shares (15.0K shares) of Nutanix at $75.10 on 2025-05-30, reducing his stake by 22.7% from 66.2K to 51.2K shares. At NTNX specifically, his prior two sales (2024-09-10 and 2024-03-01) produced mixed results: one returned +8.8% over 90 days while the other declined -12.1%, yielding a 50% well-timed rate at this ticker. The current stock price of $77.72 sits 7.1% above the 30-day average and -6.4% from the 52-week high of $83.07, positioned in the upper range of the 52-week trading band. Nutanix remains unprofitable on a full-year basis despite 15.4% annual revenue growth and a $639.0M latest-quarter revenue, with a notably elevated P/E of 863.56 driven by near-breakeven net income of $63.4M against a $20.8B market cap.

Director Gomo sells 30,000 NTNX shares at $60.05; post-sale holdings 66,200 shares after -31.2% reduction

Steven J. Gomo, a Director at Nutanix, sold 30,000 shares (30.0K shares) at $60.05 on 2024-09-10, reducing his holdings by 31.2% from 96,200 shares to 66,200 shares, for a total value of $1,801,470.00. The company remains unprofitable with net income of $-15,616,000.00 in its latest period, despite posting annual revenue growth of +17.8% with revenue at $524,577,000.00. Gomo's prior NTNX sale (2024-03-01) showed negative returns at both 30-day and 90-day intervals, representing 1 of 1 prior sells that was well-timed. With stock trading 17.2% below its 52-week high of $73.37, the director's material reduction in a loss-making company warrants observation, particularly given the company's profitability trajectory remains uncertain despite operational revenue expansion.